Wissenschaftliche Arbeiten

Doç. Dr. Fehmi Hindilerden

94 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03363-8 PMID 42565930 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2026

    DOI 10.55730/1300-0144.6184 PMID 42058976 Frei zugänglicher VolltextQuelle: OpenAlex

  3. Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15020854 PMID 41598791 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  4. (PB2953) REAL-WORLD EFFICACY AND CARDIOVASCULAR SAFETY OF ACALABRUTINIB IN B-CELL MALIGNANCIES: A TURKISH MULTICENTER EXPERIENCE COMPARING FRONTLINE INITIATION VS. TRANSITION AFTER IBRUTINIB INTOLERANCE Topic: 06. Chronic lymphocytic leukemia and related disorders -Clinical

    2026

    DOI 10.13140/rg.2.2.20277.44000 Quelle: OpenAlex

  5. Evaluation of bloodstream infections in febrile neutropenic patients with hematological malignancy: a retrospective cohort study

    BMC Infectious Diseases, 2026

    DOI 10.1186/s12879-026-13465-6 PMID 42056949 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  6. CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Mediterranean Journal of Hematology and Infectious Diseases, 2026

    DOI 10.4084/mjhid.2026.027 PMID 41821563 Frei zugänglicher VolltextQuelle: ORCID

  7. Real-World Outcomes of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

    Hemato, 2026

    DOI 10.3390/hemato7020016 Frei zugänglicher VolltextQuelle: ORCID

  8. A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond

    Blood advances, 2026

    DOI 10.1182/bloodadvances.2025017896 PMID 41092481 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  9. Emerging Survival Predictor Model in Essential Thrombocythemia: The AAA + Model

    American Journal of Hematology, 2026

    DOI 10.1002/ajh.70254 PMID 41793248 Frei zugänglicher VolltextQuelle: OpenAlex

  10. MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI

    Bursa Uludag University - AVESIS, 2025

    Quelle: OpenAlex

  11. MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI

    Kocaeli Üniversitesi - AVESİS, 2025

    Quelle: OpenAlex

  12. Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study

    Nigerian Journal of Clinical Practice, 2025

    DOI 10.4103/njcp.njcp_499_24 PMID 40462333 Frei zugänglicher VolltextQuelle: OpenAlex

  13. The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia

    Immunologic Research, 2025

    DOI 10.1007/s12026-025-09672-z PMID 40768060 1 Zitation (Europe PMC) Quelle: ORCID

  14. Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology

    Journal of Thrombosis and Thrombolysis, 2025

    DOI 10.1007/s11239-024-03043-5 PMID 39527392 5 Zitationen (Europe PMC) Quelle: ORCID

  15. ABCL-288: Cisplatin-Induced Cardiomyopathy After Salvage Chemotherapy for Non-Hodgkin Lymphoma

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/s2152-2650(25)02243-8 1 Zitation (OpenAlex) Quelle: OpenAlex

  16. A practical tool for predicting outcomes in essential thrombocythemia: Triple (or quadruple) a risk model

    Blood, 2025

    DOI 10.1182/blood-2025-3805 Quelle: OpenAlex

  17. SECONDARY SOLID CANCER FREQUENCY AND RISK FACTORS IN PHILADELPHIA- NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.005 Frei zugänglicher VolltextQuelle: OpenAlex

  18. Secondary Solid Cancers Among Patients with Philadelphia Chromosome- Negative Myeloproliferative Neoplasms: A Multicenter Study

    Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2024.0199 PMID 39113479 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  19. MPN-176 Clinical Significance of CALR Mutation in Patients With Essential Thrombocythemia

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01410-1 Quelle: OpenAlex

  20. Clinical Significance of CALR Mutation in Patients With Essential Thrombocythemia

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)00711-0 Quelle: OpenAlex

  21. Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

    Blood, 2024

    DOI 10.1182/blood-2024-193433 Frei zugänglicher VolltextQuelle: OpenAlex

  22. Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans

    Blood Coagulation & Fibrinolysis, 2024

    DOI 10.1097/mbc.0000000000001307 PMID 38973518 1 Zitation (Europe PMC) Quelle: ORCID

  23. Alectinib-induced Non-immune Hemolytic Anemia due to Erythrocyte Membrane Alterations: A Retrospective Evaluation

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2024

    DOI 10.4274/bmj.galenos.2024.2024.3-9 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  24. The Role of CD8+CXCR5+ Follicular Cytotoxic T Cell and Their Subsets in B Cell Responses and Diseases

    Istanbul University Press eBooks, 2024

    DOI 10.26650/b/ls17ls30.2025.007 Quelle: OpenAlex

  25. International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report

    Transfusion and Apheresis Science, 2023

    DOI 10.1016/j.transci.2023.103662 PMID 36842884 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  26. Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms

    Turkish Journal of Hematology, 2023

    DOI 10.4274/tjh.galenos.2023.2023.0169 PMID 37584526 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  27. Raman spectroscopy-based biomarker screening by studying the fingerprint and lipid characteristics of Polycythem..a Vera cases blood serum

    Photodiagnosis and Photodynamic Therapy, 2023

    DOI 10.1016/j.pdpdt.2023.103572 PMID 37060986 5 Zitationen (Europe PMC) Quelle: OpenAlex

  28. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

    The European Research Journal, 2023

    DOI 10.18621/eurj.1231251 Frei zugänglicher VolltextQuelle: OpenAlex

  29. POSTER: CT-236 Scabies Induced Hypereosinophilic Syndrome After Allogeneic Stem Cell Transplant: Case Report

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00920-5 Quelle: OpenAlex

  30. CT-236 Scabies Induced Hypereosinophilic Syndrome After Allogeneic Stem Cell Transplant: Case Report

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01503-3 Frei zugänglicher VolltextQuelle: OpenAlex

  31. RETROSPECTIVE EVALUATION OF BONE MARROW FINDINGS IN AUTOIMMUNE HEMOLYTIC ANEMIAS

    Hematology Transfusion and Cell Therapy, 2023

    DOI 10.1016/j.htct.2023.09.068 Frei zugänglicher VolltextQuelle: OpenAlex

  32. Systemic Immune-Inflammation Index and Hodgkin Lymphoma: an Underexplored Relationship

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.62582 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  33. Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2023

    DOI 10.4274/tjh.galenos.2023.2023.0295 PMID 37791641 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  34. ABCL-116 R-Venetoclax Treatment in a B-Cell Prolymphocytic Leukemia Patient: A Challenging Case

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01291-0 1 Zitation (OpenAlex) Quelle: OpenAlex

  35. POSTER: ABCL-116 R-Venetoclax Treatment in a B-Cell Prolymphocytic Leukemia Patient: A Challenging Case

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00741-3 Frei zugänglicher VolltextQuelle: OpenAlex

  36. The association of CMV infection with bacterial and fungal infections in hematopoietic stem cell transplant recipients: a retrospective single-center study.

    PubMed, 2022

    PMID 35403846 4 Zitationen (Europe PMC) Quelle: OpenAlex

  37. Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen

    Hematology Reports, 2022

    DOI 10.3390/hematolrep14030030 PMID 35893154 Frei zugänglicher VolltextQuelle: OpenAlex

  38. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

    Clinical Lymphoma, Myeloma and Leukemia, 2022

    DOI 10.1016/j.clml.2021.09.010 PMID 34629286 5 Zitationen (Europe PMC) Quelle: ORCID

  39. Increased Perforin- and IL-21-Expressing NK Cells in Patients with Early-Stage Chronic Lymphocytic Leukemia

    Experimed, 2022

    DOI 10.26650/experimed.1191622 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  40. RITUXIMAB INDUCED LUNG DISEASE IN A MANTLE CELL LYMPHOMA PATIENT RECEIVING MAINTENANCE: CASE PRESENTATION

    Hematology, Transfusion and Cell Therapy, 2022

    DOI 10.1016/j.htct.2022.09.1245 Frei zugänglicher VolltextQuelle: ORCID

  41. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

    Turkish Journal of Hematology, 2021

    DOI 10.4274/tjh.galenos.2021.2021.0287 PMID 34521187 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  42. Pralatrexate experience in PTCL: A multicenter retrospective study from Turkey.

    PubMed, 2021

    PMID 34565016 Frei zugänglicher VolltextQuelle: OpenAlex

  43. Pralatrexate experience in peripheral T-cell lymphoma: A multicenter retrospective study from Turkey

    AYBU AVESIS, 2021

    Quelle: OpenAlex

  44. The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021

    DOI 10.3906/sag-2103-247 PMID 34482679 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  45. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

    Journal of Chemotherapy, 2021

    DOI 10.1080/1120009x.2021.1976912 PMID 34514960 8 Zitationen (Europe PMC) Quelle: OpenAlex

  46. Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma

    Frontiers in Oncology, 2021

    DOI 10.3389/fonc.2021.601709 PMID 33816231 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  47. The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study

    International Journal of Clinical Oncology, 2021

    DOI 10.1007/s10147-021-01863-6 PMID 33486624 47 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  48. IgG4 producing POEMS syndrome: A rarely recognized subtype.

    Indian journal of pathology & microbiology, 2021

    DOI 10.4103/ijpm.ijpm_995_20 PMID 34341279 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  49. An Experience on Pomalidomide in Patients within Relapsed/Refractory Multiple Myeloma - A Multicenter Study in Turkey

    Journal of Pharmaceutical Research International, 2021

    DOI 10.9734/jpri/2020/v32i4131047 Frei zugänglicher VolltextQuelle: ORCID

  50. MPN-376: The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/s2152-2650(20)31007-7 Quelle: OpenAlex